From: Potential Drugs and Remedies for the Treatment of COVID-19: a Critical Review
 | Patient | ||||
---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | |
IL-6, pg/ml (normal range, 0–7) | |||||
Before transfusion | 70.5 | 438.2 | 63.9 | 79.1 | 87.8 |
Day 1 posttransfusion | 74.9 | NT | 118.5 | 39.3 | NT |
Day 3 posttransfusion | 34.5 | 1045.0 | 67.0 | 25.8 | 797.9 |
Day 5 posttransfusion | 24.1 | 334.1 | 590.5 | NT | NT |
Day 7 posttransfusion | 30.8 | 29.8 | 174.3 | 34.0 | 69.9 |
Day 12 posttransfusion | 6.1 | 31.8 | NT | 2.7 | 54.9 |
Length of hospital stay, d | Remains hospitalized | Remains hospitalized | 53 | 51 | 55 |
Current status as of March 25,2020 | Stable, still receiving mechanical ventilation | Stable, still receiving mechanical ventilation | Discharged home | Discharged home | Discharged home |